BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Recent Developments in the Spinal Muscular Atrophy Treatment Landscape

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Friday, October 25, 2019
Sponsor Information: 

This program is supported in part by an independent medical education grant from AveXis Inc.

Faculty

Julie A. Parsons, MD
Julie A. Parsons, MD
Professor of Clinical Pediatrics and Neurology. Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders Co-Director, Neuromuscular Clinic . University of Colorado School of Medicine and Children’s Hospital Colorado
Claudia A. Chiriboga, MD, MPH
Claudia A. Chiriboga, MD, MPH
Professor of Neurology and Pediatrics - Columbia University Irving Medical Center and New York–Presbyterian Hospital
Recent Development SMA
Activity Overview: 

This webinar will help physicians learn about rapidly changing treatment options in SMA and facilitate the integration of new treatments into the comprehensive management of patients with SMA. MDA invites clinicians in our community to use this resource to educate themselves and other providers.